Candid Therapeutics

Ouro Medicines

This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.

Caldera Therapeutics

This clinical-stage biotechnology company develops bispecific antibodies to treat patients with inflammatory bowel disease and other immune-mediated conditions.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Cabaletta Bio

This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.